Status:
COMPLETED
Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Lead Sponsor:
Bayer
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
Brief Summary
This study is a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Julina for postmenopausal osteoporosis. The objecti...
Eligibility Criteria
Inclusion
- Patients who received Julina for postmenopausal osteoporosis
Exclusion
- Patients who are contraindicated based on the product label
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT01397955
Start Date
January 1 2009
End Date
April 1 2014
Last Update
April 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Japan